These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 25753576

  • 1. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N.
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [Abstract] [Full Text] [Related]

  • 2. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [Abstract] [Full Text] [Related]

  • 3. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R.
    Neuroimage; 2009 Oct 01; 47(4):2083-9. PubMed ID: 19539037
    [Abstract] [Full Text] [Related]

  • 4. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H.
    Parkinsonism Relat Disord; 2019 Dec 01; 69():61-67. PubMed ID: 31678722
    [Abstract] [Full Text] [Related]

  • 5. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
    González-Redondo R, Toledo J, Clavero P, Lamet I, García-García D, García-Eulate R, Martínez-Lage P, Rodríguez-Oroz MC.
    Eur J Neurol; 2012 Aug 01; 19(8):1100-7. PubMed ID: 22360775
    [Abstract] [Full Text] [Related]

  • 6. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X, Wen MC, Ng SY, Hartono S, Chia NS, Choi X, Tay KY, Au WL, Chan LL, Tan EK, Tan LC.
    Eur J Neurol; 2020 Jun 01; 27(6):959-966. PubMed ID: 32124496
    [Abstract] [Full Text] [Related]

  • 7. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC.
    Parkinsonism Relat Disord; 2013 Jul 01; 19(7):680-3. PubMed ID: 23623194
    [Abstract] [Full Text] [Related]

  • 8. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.
    Mak E, Zhou J, Tan LC, Au WL, Sitoh YY, Kandiah N.
    J Neurol Neurosurg Psychiatry; 2014 May 01; 85(5):576-80. PubMed ID: 24133286
    [Abstract] [Full Text] [Related]

  • 9. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH, Lee JJ, Sunwoo MK, Hong JY, Sohn YH, Lee PH.
    Parkinsonism Relat Disord; 2016 Mar 01; 24():95-9. PubMed ID: 26776568
    [Abstract] [Full Text] [Related]

  • 10. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H, Deng B, Xie F, Yang X, Xie Z, Chen Y, Yang Z, Huang X, Zhu S, Wang Q.
    Ann Clin Transl Neurol; 2021 Sep 01; 8(9):1917-1934. PubMed ID: 34310081
    [Abstract] [Full Text] [Related]

  • 11. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH, Lee WJ, Chung SJ, Yoo HS, Jung JH, Baik K, Sohn YH, Seong JK, Lee PH.
    J Parkinsons Dis; 2021 Sep 01; 11(1):239-249. PubMed ID: 33074193
    [Abstract] [Full Text] [Related]

  • 12. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH, Yun HJ, Sunwoo MK, Hong JY, Lee JM, Sohn YH, Lee PH.
    Parkinsonism Relat Disord; 2015 Apr 01; 21(4):372-7. PubMed ID: 25697488
    [Abstract] [Full Text] [Related]

  • 13. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M, Manera AL, Ducharme S, Collins DL.
    Neurobiol Aging; 2022 Mar 01; 111():54-63. PubMed ID: 34968832
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Scamarcia PG, Agosta F, Spinelli EG, Basaia S, Stojković T, Stankovic I, Sarasso E, Canu E, Markovic V, Petrović I, Stefanova E, Pagani E, Kostic VS, Filippi M.
    Mov Disord; 2022 Feb 01; 37(2):315-324. PubMed ID: 34806799
    [Abstract] [Full Text] [Related]

  • 15. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V, Oh JM, Okonkwo O, Krislov S, Barzgari A, Theisen F, Sojkova J, Bendlin BB, Johnson SC, Gallagher CL.
    Neuroimage Clin; 2019 Feb 01; 23():101870. PubMed ID: 31150958
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.